© 2024 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
In this episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.
In this week’s episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, from the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research for the disease.
Head and neck cancer accounts for about 4 percent of all cancers in the United States, with more than 64 thousand people who have or will develop the disease this year.
In this week’s episode of CURE Talks Cancer, we spoke with Elizabeth Langdon, vice president of strategic communications and development at the Head and Neck Cancer Alliance, about how the organization helps to raise awareness for the prevention, early detection and research of head and neck cancer.
For more information, visit the Head and Neck Cancer Alliance's page on curetoday.com
Related Content: